XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Description of the Business (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 29, 2022
USD ($)
$ / shares
shares
Nov. 01, 2022
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2024
$ / shares
Mar. 31, 2024
shares
Mar. 04, 2024
$ / shares
Mar. 31, 2023
shares
Oct. 25, 2022
USD ($)
$ / shares
Mar. 01, 2022
shares
Dec. 31, 2021
shares
Organization and Business Operations (Details) [Line Items]                              
Share price (in Dollars per share) | $ / shares $ 10.115                       $ 13.05    
Stock repurchased during period, shares 375,939                            
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares     $ 0.0001   $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001            
Accumulated deficit | $     $ (42,684,051)   $ (42,684,051)   $ (38,171,483) $ (25,345,566)              
Common Stock, Shares, Issued     23,124,888   23,124,888   23,124,888 21,713,248              
Repurchase and retirement of share under Forward Share Purchase Agreement 375,939                            
Escrow deposit | $                         $ 4,551,750    
Escrow deposit disbursements related to property acquisition | $ $ 4,551,750                            
Common stock convertible exchange ratio   2.0719         2.0719                
Net Income (Loss) | $     $ (2,077,867) $ (5,944,227) $ (4,512,568) $ (12,711,060) $ (12,825,917) $ (13,088,717)              
Investor [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Escrow deposit disbursements related to property acquisition | $ $ 3,802,623                            
Peak Bio Company Limited [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Accumulated deficit | $     $ 42,600,000   42,600,000                    
Peak Bio Company Limited [Member] | PIPE Shares [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Number of sale of units   176,579                          
December 2023 Convertible Notes [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Proceeds from Convertible Debt | $             700,000                
May 2024 Convertible Notes [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Proceeds from Convertible Debt | $         $ 2,000,000   3,500,000                
Senior Secured Promissory Note [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Proceeds from issuance of secured note | $             $ 750,000                
New Subscriber [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Share price per units (in Dollars per share) | $ / shares   $ 10                          
Share price (in Dollars per share) | $ / shares   $ 0.01                          
Less: proceeds from issuance of shares to PIPE subscribers | $   $ 3,025,000                          
New Subscriber [Member] | PIPE Shares [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Number of sale of units   302,500                          
Original Subscriber [Member] | Original PIPE Shares [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Share price per units (in Dollars per share) | $ / shares   $ 10                          
Number of sale of units   50,000                          
Less: proceeds from issuance of shares to PIPE subscribers | $   $ 500,000                          
Akari Ordinary Shares [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares                     $ 0.0001        
Akari American Depositary Shares [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Percentage of expected ownership in outstanding shares                     50.00%        
Common Stock                              
Organization and Business Operations (Details) [Line Items]                              
Shares Outstanding     23,124,888 20,862,177 23,124,888 20,862,177 23,124,888 19,782,747   23,124,888   20,195,510   17,162,742 17,162,742
Repurchase and retirement of share under Forward Share Purchase Agreement               375,939              
Number of sale of units               402,500              
Minimum requirement of shares held by shareholders   1,000,000                          
PIPE Financing Warrants [Member] | New Subscriber [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Number of sale of units   281,325                          
PIPE Warrants [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Share price (in Dollars per share) | $ / shares   $ 0.01                          
Class of warrant or right, term from which warrants or rights exercisable   1 year                          
Warrant expiration date             Nov. 01, 2023                
PIPE Warrants [Member] | Peak Bio Company Limited [Member]                              
Organization and Business Operations (Details) [Line Items]                              
Number of sale of units   164,220